Current Neuro-Oncology




Volume 28 Number 14
20 May 2026




Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 14, 20 May






Abdi S, Poikonen-Saksela P, Halonen P, Tynninen O, Reardon DA, Hernberg M. A
10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma.
Acta Oncol. 2026 May 11;65:412-415. doi: 10.2340/1651-226X.2026.45543. PMID: 42109078. ˍ




Garfinkle EAR, Perales-Linares R, Gimple RC, Livingstone AJ, Roberts KF, Butt OH, Goedegebuure SP, McLellan MD, Chang GS, Hundal J, Yan J, Navarro JB, Paxton SA, Chattopadhyay S, Cooch N, Perales-Puchalt A, Stavroulaki K, Rochestie S, Peters J, Junker B, Campian JL, Chheda MG, Chicoine MR, Kim AH, Willie JT, Zipfel GJ, Dowling JL, Miller CA, Griffith OL, Griffith M, Gillanders WE, Miller KE, Mardis ER, Sardesai NY, Dunn GP, Johanns TM.
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.
Nat Cancer. 2026 May 12. doi: 10.1038/s43018-026-01163-w. PMID: 42120910. Trial registration ID: NCT04015700. ˍ




Pantalone MR, Stragliotto G, Martin-Almazan N, Peredo-Harvey I, Jimenez-Macias JL, Rahbar A, Lawler S, Bartek J, Söderberg-Naucler C.
Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.
Cancers (Basel). 2026 May 12;18(10):1575. doi: 10.3390/cancers18101575. PMID: 42192935. Trial registration ID: NCT00400322. ˍ




Detsky JS, Chan AW, Moore-Palhares D, Safavi AH, Perry J, Fat MJL, Atenafu EG, Das S, Lipsman N, Heyn C, Maralani P, Czarnota GJ, Ruschin M, Keller B, Lau A, Chen H, Myrehaug SD, Soliman H, Tseng CL, Sahgal A.
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.
Lancet Oncol. 2026 May 14;27(6):729-737. doi: 10.1016/S1470-2045(26)00088-4. PMID: 42134380. Trial registration ID: NCT04726397˰ ˍ




Li G, Zheng M, Zhang X, Yin X, Li S, Liu X, Peng Y.
Intraoperative Mean Arterial Pressure and Postoperative Deep Vein Thrombosis in Patients Undergoing Craniotomy for Presumed High-Grade Glioma Resection: A Secondary Analysis of a Randomized Controlled Trial.
World Neurosurg. 2026 May 14;212:125053. doi: 10.1016/j.wneu.2026.125053. PMID: 42140316. Trial registration ID: NCT03323580. ˍ




Ghosh S, Stewart J, Ruschin M, Chen H, Tseng CL, Soliman H, Sahgal A, Detsky J.
Influence of FLAIR inclusion on patterns-of-failure and outcomes in glioblastoma: results from the UNITED prospective adaptive radiotherapy trial.
Radiother Oncol. 2026 May 15;220:111579. doi: 10.1016/j.radonc.2026.111579. PMID: 42142536. Trial registration ID: NCT04726397. ˍ




Giorgia I, Mauro P, Lorenzo A, Federica N, Tamara I, Valerio DR, Daniele A, Antonio S, Maurizio S, Alessandro F, Alessandro P.
Subventricular zone involvement and cortico-spinal tract infiltration as predictors of outcome in Glioblastomas: a distinct surgical, clinical and prognostic entity.
J Clin Neurosci. 2026 May 17;151:112087. doi: 10.1016/j.jocn.2026.112087. PMID: 42143483˰ ˍ




Sener U, Neth B, Galloway T, Hughes H, Caron S, Batty NR, Alden EC, Stricker NH, Stricker JL, Kizilbash SH, Breen WG, Lehrer E, Campian J, Uhm J, Ruff MW, D'Andre SD, Burns TC, Haddad TC, Flickinger LM, Chan K, Mead-Harvey C, Geyer SM.
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of metformin on cognition and quality of life in patients with history of cranial radiation.
Contemp Clin Trials Commun. 2026 May 18;51:101648. doi: 10.1016/j.conctc.2026.101648. PMID: 42211793. Trial registration ID: NCT06377696. ˍ




Bindal K, Dono A, Tandon N, Esquenazi Y.
Laser interstitial thermal therapy versus stereotactic radiosurgery for first-time treatment of recurrent glioblastoma: a retrospective single-center study.
J Neurooncol. 2026 May 19;178(1):6. doi: 10.1007/s11060-026-05632-1. PMID: 42151639. ˍ




Hashii Y, Fujisaki H, Terashima K, Goto H, Horibe K, Sugiyama K, Takahara-Matsubara M, Goto M, Yanagisawa T, Kikuta A, Kawamoto H, Hashimoto N, Oka Y, Sugiyama H, Hara J.
Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma.
Eur J Cancer. 2026 May 19;242:116808. doi: 10.1016/j.ejca.2026.116808. PMID: 42176363. Trial registration ID: NCT02750891˰ ˍ




McKay CJL, Mayoh C, Power P, Jessop S, Sriharan S, Staunton J, Trinder S, Zhukova N, Mignone C, Govender D, Alvaro F, Downie P, Hansford JR, Hassall T, Valvi S, Mateos MK, Barahona P, Gifford AJ, Tax G, Tsoli M, Dolman EM, Wong M, Cowley M, Marshall GM, Trahair TN, Ekert PG, Haber M, Tyrell V, Lau LMS, Manoharan N, Ziegler DS, Khuong-Quang DA.
Precision-guided therapy in H3K27-altered diffuse midline glioma.
Nat Commun. 2026 May 19. doi: 10.1038/s41467-026-73304-9. PMID: 42156385. Trial registration ID: NCT03336931. ˍ




van der Weijden CWJ, Jeltema HR, Wagemakers M, Enting RH, Stormezand G, Kramer MCA, van Dijken BRJ, van der Hoorn A.
Impact on survival of glioblastoma patient's in relation to the imaging of the peri-surgical area: a multi-parametric diffusion MRI, perfusion MRI and [11C]MET PET study.
Br J Radiol. 2026 May 20:tqag117. doi: 10.1093/bjr/tqag117. PMID: 42162948. ˍ








Besch G, Thines L, Bronnert R, Boitel A, Scaringella N, Hammoudi F, Hamdan N, Charpentier H, Villeneuve J, Clairet AL, Vettoretti L, Ferreira D, Berthier F, Pili-Floury S.
Clinical effectiveness of intravenous hypertonic sodium lactate infusion for intra-operative brain relaxation in supratentorial brain tumour surgery: A double-blind randomised phase II pilot study.
Eur J Anaesthesiol. 2026 May 8. doi: 10.1097/EJA.0000000000002414. PMID: 42109031. Trial registration ID: NCT04488874˰ ˍ




Heggebø LC, Fjæra LF, Garrote FLB, Borgen IMH, Blakstad H, Hellebust TP, Saxhaug C, Knutstad K, Rylander H, Henry T, Gustafsson M, Werlenius K, Blomstrand M, Brandal P.
Case Report: Proton beam therapy - friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
Front Oncol. 2026 May 8;16:1803943. doi: 10.3389/fonc.2026.1803943. PMID: 42180039. ˍ




Nikopoulou A, Grosomanidis V, Poulopoulou A, Vyzantiadis TA, Pourzitaki C, Patsalas I, Tsaousi GG.
Effect of dexmedetomidine on cerebral homeostasis in patients undergoing craniotomy for brain tumour excision: A randomized double-blind trial.
Br J Clin Pharmacol. 2026 May 8. doi: 10.1002/bcp.70606. PMID: 42103466. Trial registration ID: Unidentified˰ ˍ